Phillyrin Attenuates Glucocorticoid‐Induced Osteoporosis by Suppressing Ferroptosis via the Nrf2/Keap1 Axis

Extended glucocorticoids treatment is a primary cause of secondary osteoporosis, termed glucocorticoids‐induced osteoporosis (GIOP), characterized by rapid bone loss and an increased fracture risk. Phillyrin (PHI), a natural lignan derived from Forsythia suspensa , possesses well‐documented antioxidant properties; however, its role in GIOP remains unexplored. This study investigates whether PHI protects against dexamethasone (Dex)‐induced ferroptosis and GIOP and elucidates the involvement of the Nrf2/Keap1 signaling axis. A GIOP mouse model was created using intraperitoneal Dex injections, while BMSCs were exposed to Dex in vitro to induce ferroptosis. The effects of PHI were assessed using C11‐BODIPY, FerroOrange, mitochondrial function assays, Western blotting, immunofluorescence, micro‐CT, and histology. Our results revealed that PHI reduced lipid peroxidation, restored mitochondrial membrane potential, and recovered the osteogenic differentiation potential of BMSCs. Mechanistically, PHI promoted Nrf2 nuclear translocation by reducing its association with Keap1, thereby upregulating NQO1, HO‐1, and downstream antioxidant enzymes. Nrf2 knockdown using siRNA eliminated PHI's protective effects in vitro, while in vivo, Nrf2 knockdown lentivirus administration markedly reduced PHI's therapeutic efficacy. In conclusion, this study provides the first evidence that PHI mitigates GIOP by preventing ferroptosis. Mechanistically, PHI activates the Nrf2/Keap1 signaling pathway, upregulating downstream antioxidant enzymes and restoring mitochondrial function to preserve BMSCs' osteogenic potential.

Authors

Institutions

Publication Details

Journal
Phytotherapy Research
Published
2026-11-21
DOI
https://doi.org/10.1002/ptr.70483
Primary Topic
Bone Metabolism and Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Phillyrin Attenuates Glucocorticoid‐Induced Osteoporosis by Suppressing Ferroptosis via the Nrf2/Keap1 Axis

Jian Li, Ming‐Jian Wu, Tao Sun, Ding‐chao Li et al.
Phytotherapy Research
Bone Metabolism and Diseases
article

Phillyrin Attenuates Glucocorticoid‐Induced Osteoporosis by Suppressing Ferroptosis via the Nrf2/Keap1 Axis

Jian Li, Ming‐Jian Wu, Tao Sun, Ding‐chao Li, Hai‐Lin Xing, Xiang Zheng, Ke‐jun Zhu
article en

Abstract

Extended glucocorticoids treatment is a primary cause of secondary osteoporosis, termed glucocorticoids‐induced osteoporosis (GIOP), characterized by rapid bone loss and an increased fracture risk. Phillyrin (PHI), a natural lignan derived from Forsythia suspensa , possesses well‐documented antioxidant properties; however, its role in GIOP remains unexplored. This study investigates whether PHI protects against dexamethasone (Dex)‐induced ferroptosis and GIOP and elucidates the involvement of the Nrf2/Keap1 signaling axis. A GIOP mouse model was created using intraperitoneal Dex injections, while BMSCs were exposed to Dex in vitro to induce ferroptosis. The effects of PHI were assessed using C11‐BODIPY, FerroOrange, mitochondrial function assays, Western blotting, immunofluorescence, micro‐CT, and histology. Our results revealed that PHI reduced lipid peroxidation, restored mitochondrial membrane potential, and recovered the osteogenic differentiation potential of BMSCs. Mechanistically, PHI promoted Nrf2 nuclear translocation by reducing its association with Keap1, thereby upregulating NQO1, HO‐1, and downstream antioxidant enzymes. Nrf2 knockdown using siRNA eliminated PHI's protective effects in vitro, while in vivo, Nrf2 knockdown lentivirus administration markedly reduced PHI's therapeutic efficacy. In conclusion, this study provides the first evidence that PHI mitigates GIOP by preventing ferroptosis. Mechanistically, PHI activates the Nrf2/Keap1 signaling pathway, upregulating downstream antioxidant enzymes and restoring mitochondrial function to preserve BMSCs' osteogenic potential.

Phytotherapy Research
Lishui Central Hospital (CN)
Bone Metabolism and Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon